Endovascular Engineering ENGULF Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 177 participants.
Also called NCT05597891
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 177 participants
- Sponsor
- Endovascular Engineering
- Registry
-
NCT05597891
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT05597891. Allocation not applicable; no masking; primary purpose treatment. Start 2023-01-12 (actual); primary completion 2026-03-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Endovascular Engineering ENGULF Study
- Acronym
- ENGULF
- Condition
- Pulmonary Embolism
- Intervention (Device)
- Hēlo PE Thombectomy System
- Lead sponsor
- Endovascular Engineering
Record details
- Record id
cardio:ct-nct05597891- Content hash
171fecace0f359cfe264c2f1d3a76e12b2977add2c398696b2778b2602801ca4